Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietin for the repair of cerebral injury in very preterm infants
2014-000612-34Phase 3Completed
- Sponsor
- University Hospital Zurich
- Start
- Oct 2015
- Modality
- Erythropoietins → Hormones & Growth Factors → Recombinant Proteins and Enzymes, Interleukins → Cytokines & Interferons → Recombinant Proteins and Enzymes, Colony Stimulating Factors → Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in brain hemorrhage (ICH), Neurodevelopmental disorder (NDD) and cerebral palsy (CP) comparing epoetin beta with placebo (2 arms). Primary endpoint: Intelligence quotient at 5 years of age. Started Oct 2015; status: completed.
02
Drugs
epoetin beta
03
Conditions
brain hemorrhage (ICH)Neurodevelopmental disorder (NDD)cerebral palsy (CP)
Beyond the preview
Go deeper on 2014-000612-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000612-34.